[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Negative Pressure Wound Therapy Systems Market Insights, Competitive Landscape and Market Forecast–2026

January 2022 | 100 pages | ID: N142C2475C05EN
DelveInsight

US$ 4,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 7-10 Business Days

Negative Pressure Wound Therapy Systems Market By Product Type (Conventional NPWT Devices, Single-Use NPWT Devices), By Wound Type (Pressure Ulcers, Diabetic Ulcers, Venous Ulcers, Others), By End-User (Hospitals, Specialty Clinics, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to the rising incidence of chronic wounds and increase in the aging population

Global Negative Pressure Wound Therapy Systems (NPWT) Market was valued at USD 3.19 billion in 2020, growing at a CAGR of 5.03% during the forecast period from 2021 to 2026, in order to reach 4.28 billion by 2026. Factors such as the rising incidence of chronic wounds associated with various chronic disorders such as diabetes, ulcers, obesity, and also with the rising incidence of active wounds comprising burns, surgical wounds, among others are driving the overall market growth. Further, an increase in the aging population, increasing awareness of proper wound care management, rising funding for wound care research, and technological advancements in wound care product offerings are also driving the market.

Negative Pressure Wound Therapy Systems Market Dynamics:

Negative Pressure Wound Therapy Systems (NPWT) is increasing gradually, one of the main reasons driving the Negative Pressure Wound Therapy Systems (NPWT) market growth is the rising incidence of chronic and acute wounds associated with various disorders. According to the Wound Healing Society, chronic wounds are classified into four categories: pressure ulcers, diabetic ulcers, venous ulcers, and arterial insufficiency ulcers. Chronic wounds have a significant impact on the health and quality of life of patients and their families. They can cause pain, loss of function and mobility, depression, pain and anxiety, shame and social isolation, financial burden, long-term hospitalization and chronic diseases, and even death. Therefore, to properly treat chronic wounds, Negative Pressure Wound Therapy Systems products are required, which in turn is expected to drive the Global Negative Pressure Wound Therapy Systems market.

Another factor driving the demand in the growth of the Negative Pressure Wound Therapy Systems market is the rising geriatric population. According to the United Nations World Population Ageing 2020 Highlights, there were about 727 million people over the age of 65 worldwide in 2020. The aforementioned source further mentioned that the elderly population is expected to double to more than 1.5 billion in the next three decades. The elderly population is more prone to the development of various chronic disorders. Thus, the increasing prevalence of chronic wounds among the aging population is also expected to increase the demand for the Global Negative Pressure Wound Therapy Systems Market.

However, factors such as the cost of these devices are very high and there is a constant risk of infections associated with reusable Negative Pressure Wound Therapy Systems that may inhibit the growth of Negative Pressure Wound Therapy Systems in the market.

Along with the above-mentioned factors, the Negative Pressure Wound Therapy Systems market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Negative Pressure Wound Therapy Systems in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Negative Pressure Wound Therapy Systems is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Negative Pressure Wound Therapy Systems market during the forecast period from 2021-2026.

Negative Pressure Wound Therapy Systems Market Segment Analysis:

Negative Pressure Wound Therapy Systems Market by Product Type (Conventional NPWT Devices, Single-Use NPWT Devices), By Wound Type (Pressure Ulcers, Diabetic Ulcers, Venous Ulcers, Others), By End-User (Hospitals, Specialty Clinics, And Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on Product Type, in the Negative Pressure Wound Therapy Systems market, the Single-Use Negative Pressure Wound Therapy Systems are predicted to witness the fastest growth during the forecast period from 2021-2026. The adoption of Single-Use Negative Pressure Wound Therapy Systems is increasing as these devices are convenient to use and are lightweight. These devices have reduced the risk of contamination that prevents the patient from costly readmissions. These devices have advanced features like simultaneous irrigation that helps in faster wound healing.

Moreover, a new development in the product lines and new product launches are bolstering the segment growth of the Negative Pressure Wound Therapy Systems market during the forecasted period. For instance, in March 2020 Smith+Nephew announced the US launch of the new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) which has a pump duration of up to 14 days and requires less user intervention. Therefore, their increased demand is expected to contribute to the overall growth of the Negative Pressure Wound Therapy Systems market growth in the coming years.

North America is expected to dominate the Overall Negative Pressure Wound Therapy Systems Market:

Among all the regions, North America is expected to account for the largest share in the Negative Pressure Wound Therapy Systems market. This domination can be primarily attributed to the rising prevalence of chronic conditions that ultimately result in chronic, surgical, and traumatic wounds, rising incidence of burn injuries, increase in expenditure on surgical and chronic wounds, and technological advancements in this region.

According to the American Burn Association (ABA) National Burn Repository 2019, flame burns are still the majority of injuries in the US (43%), with scalds second at 34% followed by contact at 9%, electrical burn injuries (4%), chemical (3%) and other (7%). Moreover, diabetic foot ulcers, a type of chronic wound in diabetic patients may also contribute to the market growth in the region due to rising cases of diabetes. For instance, as per the National Diabetes Statistics Report 2021, approximately 34.2 million people have diabetes which comprises 10.5% of the US population. Thus these critical condition is likely to increase the risk of developing chronic wounds thereby augmenting the market for Negative Pressure Wound Therapy Systems market. In addition, rising surgical procedures is also one of the major factors driving the Negative Pressure Wound Therapy Systems market growth.

Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals as well as better healthcare facilities and reimbursement programs coupled with the presence of major market players as well as higher investment in the research and development activities in the region are predicted to be the major influencing factors in driving the overall growth of the Negative Pressure Wound Therapy Systems over the forecast period.

In North America, the US is expected to account for the largest share in the Negative Pressure Wound Therapy Systems market. This can be attributed to the increasing cases of wound disorders in the country and the rising geriatric population. As per the United States Census Bureau 2019, in the United States, 3% of the population older than 65 years have open wounds. By the year 2060, the US government estimates that the elderly population will be over 77 million, suggesting that chronic wounds will continue to be an increasingly persistent problem in this population. This increase in the wounds affected population would lead to the increased use of Negative Pressure Wound Therapy Systems in the country which in turn will contribute to the increasing demand for Negative Pressure Wound Therapy Systems thereby aiding in the growth of the Negative Pressure Wound Therapy Systems market in the country and as well as the region.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region are going to boost the North America Negative Pressure Wound Therapy Systems market during the forecast period.

Negative Pressure Wound Therapy Systems Market Key Players:

Some of the key market players operating in the Negative Pressure Wound Therapy Systems market include 3M, Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mцlnlycke Health Care AB, Direct Healthcare Group, Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp., PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., OncoVista Innovative Therapies, Genadyne, Cork Medical, LLC among others.

Recent Developmental Activities in the Negative Pressure Wound Therapy Systems Market:

In August 2021, Aatru Medical, LLC announced the US Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System. The FDA-cleared miniaturized device is designed to help heal open wounds after surgery by sealing and holding them shut using gentle suction.

In April 2021, Joerns Healthcare and Medela announced a nationwide partnership to develop access to innovative negative pressure wound therapy systems. Through this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.

In June 2019, 3M acquired Acelity L.P. Inc. for $6.7 billion to enhance its strategy for advanced wound care solutions and accelerate the penetration of NPWT products internationally.

Key Takeaways from the Negative Pressure Wound Therapy Systems Market Report Study

Market size analysis for Negative Pressure Wound Therapy Systems market size (2020), and market forecast for 5 years (2021-2026)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Negative Pressure Wound Therapy Systems market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Negative Pressure Wound Therapy Systems market.

Various opportunities available for the other competitor in the Negative Pressure Wound Therapy Systems market space.

What are the top performing segments in 2020? How these segments will perform in 2026.

Which is the top-performing regions and countries in the current Negative Pressure Wound Therapy Systems market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Negative Pressure Wound Therapy Systems market growth in the coming future?

Target Audience who can be benefited from this Negative Pressure Wound Therapy Systems Market Report Study

Negative Pressure Wound Therapy Systems products providers

Research organizations and consulting companies

Negative Pressure Wound Therapy Systems -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Negative Pressure Wound Therapy Systems

Various End-users who want to know more about the Negative Pressure Wound Therapy Systems market and latest technological developments in the Negative Pressure Wound Therapy Systems market.

Frequently Asked Questions for Negative Pressure Wound Therapy Systems Market:

1. What are Negative Pressure Wound Therapy Systems?

Negative pressure wound therapy (NPWT), also known as vacuum-assisted wound closure is a wound dressing system that provides continuous or intermittent subatmospheric pressure to the system which further provides positive pressure to the surface of a wound. NPWT devices are used to treat acute and chronic wounds. These devices are categorized as FDA Class II devices that consist of a vacuum pump, drainage tubing, and wound dressing set requiring electricity to maintain its use. The devices are also used to remove fluids such as wound exudate, irrigation fluids, bodily fluids, or infectious materials.

2. What is the market for Global Negative Pressure Wound Therapy Systems?

Global Negative Pressure Wound Therapy Systems Market was valued at USD 3.19 billion in 2020, growing at a CAGR of 5.03% during the forecast period from 2021 to 2026 to reach 4.28 billion by 2026.

3. What are the drivers for Global Negative Pressure Wound Therapy Systems Market?

The major drivers of the global Negative Pressure Wound Therapy Systems market are the rising incidence of chronic wounds associated with various chronic disorders such as diabetes, ulcers, obesity and also with the rising incidence of active wounds comprising burns, surgical wounds, among others, increase in the aging population, increasing awareness of proper wound care management, rising funding for wound care research, and technological advancements in wound care product offerings.

4. Who are the key players operating in the Global Negative Pressure Wound Therapy Systems Market?

Some of the key market players operating in the Negative Pressure Wound Therapy Systems market includes 3M (Acelity L.P. Inc.), Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mцlnlycke Health Care AB, Talley Group Ltd., Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp., PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., Innovative Therapies, Genadyne, Cork Medical, LLC and others.

5. Which region has the highest share in the Negative Pressure Wound Therapy Systems market?

Among all the regions, North America is expected to amass the largest share of the Negative Pressure Wound Therapy Systems market. This domination can be primarily attributed to the rising prevalence of chronic conditions that ultimately result in chronic, surgical, and traumatic wounds, rising incidence of burn injuries, increase in expenditure on surgical and chronic wounds, and technological advancements in this region.
1.NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET REPORT INTRODUCTION

2.NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET EXECUTIVE SUMMARY

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. REGULATORY AND PATENT ANALYSIS

3.1 The United States
3.2 Europe
3.3 Japan
3.4 China

4. NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET KEY FACTORS ANALYSIS

4.1 Negative Pressure Wound Therapy Systems Market Drivers
  4.1.1 The Rising Incidence of Chronic and Acute Wounds
  4.1.2 Increasing Awareness of Proper Wound Care Management
  4.1.3 Growing Aging Population
  4.1.4 Technological Advancements in Wound Care Product Offerings
4.2 Negative Pressure Wound Therapy Systems Market Restraints and Challenges
  4.2.1 High Cost of NPWT systems
  4.2.2 Risk of Infections Associated with Reusable Negative Pressure Wound Therapy Systems
4.3 Negative Pressure Wound Therapy Systems Market Opportunities
  4.3.1 Growing market potential in the wound care market
  4.3.2 Faster Adoption of Single-use Negative Pressure Wound Therapy Systems

5. NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET PORTER’S FIVE FORCES ANALYSIS

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 IMPACT ANALYSIS ON NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET

7. NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET LAYOUT

7.1 By Product Type
  7.1.1 Conventional NPWT Devices
  7.1.2 Single-Use NPWT Devices
7.2 By Wound Type
  7.2.1 Pressure Ulcers
  7.2.2 Diabetic Ulcers
  7.2.3 Venous Ulcers
  7.2.4 Others
7.3 By End User
  7.3.1 Hospitals
  7.3.2 Specialty Clinics
  7.3.3 Others
7.4 By Geography
  7.4.1 North America
    7.4.1.1 North America Negative Pressure Wound Therapy Systems Market, by Product Type
    7.4.1.2 North America Negative Pressure Wound Therapy Systems Market, by Wound Type
    7.4.1.3 North America Negative Pressure Wound Therapy Systems Market, by End User
    7.4.1.4 North America Negative Pressure Wound Therapy Systems Market, by Country
      7.4.1.4.1 United States
      7.4.1.4.2 Canada
      7.4.1.4.3 Mexico
  7.4.2 Europe
    7.4.2.1 Europe Negative Pressure Wound Therapy Systems Market, by Product Type
    7.4.2.2 Europe Negative Pressure Wound Therapy Systems Market, by Wound Type
    7.4.2.3 Europe Negative Pressure Wound Therapy Systems Market, by End User
    7.4.2.4 Europe Negative Pressure Wound Therapy Systems Market, by Country
      7.4.2.4.1 France
      7.4.2.4.2 Germany
      7.4.2.4.3 United Kingdom
      7.4.2.4.4 Italy
      7.4.2.4.5 Spain
      7.4.2.4.6 Russia
      7.4.2.4.7 Rest of Europe
  7.4.3 Asia-Pacific
    7.4.3.1 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Product Type
    7.4.3.2 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Wound Type
    7.4.3.3 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by End User
    7.4.3.4 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Country
      7.4.3.4.1 China
      7.4.3.4.2 Japan
      7.4.3.4.3 India
      7.4.3.4.4 Australia
      7.4.3.4.5 South Korea
      7.4.3.4.6 Rest of Asia Pacific
  7.4.4 Rest of the World (RoW)
    7.4.4.1 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Product Type
    7.4.4.2 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Wound Type
    7.4.4.3 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by End User
    7.4.4.4 Asia-Pacific Negative Pressure Wound Therapy Systems Market, by Region
      7.4.4.4.1 Middle East
      7.4.4.4.2 Africa
      7.4.4.4.3 South America

8. NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES

9. NEGATIVE PRESSURE WOUND THERAPY SYSTEMS MARKET COMPANY AND PRODUCT PROFILES

9.1 3M
  9.1.1. Company Overview
  9.1.2. Company Snapshot
  9.1.3. Financial Overview
  9.1.4 Product Listing
  9.1.5. Entropy
9.2 Cardinal Health
  9.2.1. Company Overview
  9.2.2. Company Snapshot
  9.2.3. Financial Overview
  9.2.4 Product Listing
  9.2.5. Entropy
9.3 ConvaTec Group PLC
  9.3.1. Company Overview
  9.3.2. Company Snapshot
  9.3.3. Financial Overview
  9.3.4 Product Listing
  9.3.5. Entropy
9.4 DeRoyal Industries, Inc.
  9.4.1. Company Overview
  9.4.2. Company Snapshot
  9.4.3. Financial Overview
  9.4.4 Product Listing
  9.4.5. Entropy
9.5 Devon Group
  9.5.1. Company Overview
  9.5.2. Company Snapshot
  9.5.3. Financial Overview
  9.5.4 Product Listing
  9.5.5. Entropy
9.6 Medela AG
  9.6.1. Company Overview
  9.6.2. Company Snapshot
  9.6.3. Financial Overview
  9.6.4 Product Listing
  9.6.5. Entropy
9.7 Smith & Nephew PLC
  9.7.1. Company Overview
  9.7.2. Company Snapshot
  9.7.3. Financial Overview
  9.7.4 Product Listing
  9.7.5. Entropy
9.8 Mцlnlycke Health Care AB
  9.8.1. Company Overview
  9.8.2. Company Snapshot
  9.8.3. Financial Overview
  9.8.4 Product Listing
  9.8.5. Entropy
9.9 Talley Group Ltd.
  9.9.1. Company Overview
  9.9.2. Company Snapshot
  9.9.3. Financial Overview
  9.9.4 Product Listing
  9.9.5. Entropy
9.10 Accel-Heal Technologies Ltd.
  9.10.1. Company Overview
  9.10.2. Company Snapshot
  9.10.3. Financial Overview
  9.10.4 Product Listing
  9.10.5. Entropy
9.11 B. Braun Melsungen AG
  9.11.1. Company Overview
  9.11.2. Company Snapshot
  9.11.3. Financial Overview
  9.11.4 Product Listing
  9.11.5. Entropy
9.12 Lohmann & Rauscher
  9.12.1. Company Overview
  9.12.2. Company Snapshot
  9.12.3. Financial Overview
  9.12.4 Product Listing
  9.12.5. Entropy
9.13 Cenefom Corp.
  9.13.1. Company Overview
  9.13.2. Company Snapshot
  9.13.3. Financial Overview
  9.13.4 Product Listing
  9.13.5. Entropy
9.14 PAUL HARTMANN Asia-Pacific Ltd.
  9.14.1. Company Overview
  9.14.2. Company Snapshot
  9.14.3. Financial Overview
  9.14.4 Product Listing
  9.14.5. Entropy
9.15 Carilex Medical
  9.15.1. Company Overview
  9.15.2. Company Snapshot
  9.15.3. Financial Overview
  9.15.4 Product Listing
  9.15.5. Entropy
9.16 Chongqing Sunshine Medical Industry and Trading Co., Ltd.
  9.16.1. Company Overview
  9.16.2. Company Snapshot
  9.16.3. Financial Overview
  9.16.4 Product Listing
  9.16.5. Entropy
9.17 Foryou Medical Electronics Co., Ltd.
  9.17.1. Company Overview
  9.17.2. Company Snapshot
  9.17.3. Financial Overview
  9.17.4 Product Listing
  9.17.5. Entropy
9.18 Innovative Therapies
  9.18.1. Company Overview
  9.18.2. Company Snapshot
  9.18.3. Financial Overview
  9.18.4 Product Listing
  9.18.5. Entropy
9.19 Genadyne
  9.19.1. Company Overview
  9.19.2. Company Snapshot
  9.19.3. Financial Overview
  9.19.4 Product Listing
  9.19.5. Entropy
9.20 Cork Medical, LLC
  9.20.1. Company Overview
  9.20.2. Company Snapshot
  9.20.3. Financial Overview
  9.20.4 Product Listing
  9.20.5 Entropy

10. KOL VIEWS

11. PROJECT APPROACH

12. ABOUT DELVEINSIGHT

13. DISCLAIMER & CONTACT US


More Publications